PPT-Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively

seroconversion and genetically linked HCV infections   CoAuthors H Guarino R Almenana E Goodbody C Salvati Presenter Pedro MateuGelabert PhD CUNY Graduate School of Public Health amp Health Policy. 11 3266 2453 4819 3483 4819 3483 3604 3604 Anthem Dentegra Dentegra Family Plan Type High Low High Low Low High Low High Low High Low Low Low Diagnostic Preventive DP 100 80 100 100 100 100 100 100 100 100 100 100 100 Basic Services 75 60 80 50 60 8 people who inject drugs . Fabienne Hariga, MD, MPH. Senior HIV Adviser, UNODC Vienna. . Co-sponsor. HIV among People who Use Drugs. HIV in . Prison Settings. CONVENING AGENCY. Prevalence of HIV among people . People Who Inject Drugs . in Ukraine: . Modelling . its . Role . in HIV . Transmission . and . the Impact . of . Introducing . OST in . Prisons. Jack Stone, Ellen Brooks-Pollock, Frederick Altice, . Lyuba. Prevalence. . among. . People. . Who. . Inject. . Drugs. : . Results. . from. . the. . First. . Integrated. Bio-. behavioral. . Survey. . of. PWID . in. Mozambique. Authors. : . Cynthia SEMÁ-BALTAZAR. in Prisoners. HIV and related infections in prisoners. The Perfect Storm. :. Incarceration and the High Risk Environment Perpetuating HIV, HCV and Tuberculosis in Eastern Europe and Central Asia. Frederick L Altice: Yale University, USA. Laura . Fernàndez. -López. lflopez@iconcologia.net . CEEISCAT. 1. Session. . organized. . by. Disclaimers. 2. This meeting is part of the joint action ‘677085 / HA-REACT,’ which has received funding from the European Union’s Health . HepCare Europe No-one gets left behind: addressing the hidden burden of HCV related advanced liver disease in PWID in the community Dr John Lambert, Professor of Medicine and Consultant in Infectious Diseases, Mater Hospital and UCD Dublin Dr. Sabrina . Sharmin. . Médecins. . Sans . Frontières/ Doctors Without Borders, . 22nd International AIDS . Conference. July 23. rd. , 2018. Conflict . of interest to declare. I . have no personal or financial interests to declare: I have no financial support from an industry source at the current presentation. Aptima HCV RNA Qualitative Assay1 500237 Rev. 003 Aptima For in vitro diagnostic use.100 test kit. General Information................................................................................2I Conrmed Unconrmed Unconrmed  Samples with high signal-to-cut-off ratios usually (�95%) conrm positive, but supplemental serologic testing was not performed PARTNERSHIP TOWARDS ELIMINATION OF A MAJOR PUBLIC HEALTH THREAT BY 2030. Wifi. : . Welcome. Hugh Morris, Chair, London Drug and Alcohol Policy Forum. . Introduction: How we can work together to achieve elimination. St John, . The National Centre for Early Music, York Minster and York Museums Trust. The Festival explores a series of intriguing links between past and present, showcasing contemporary ideas, arts and culture, and brings these ideas into conversation with the heritage of the city to reveal new and exciting stories about York, Britain and the world.  . HCV . GT 1,4, or 6 in PWID* on Opiate Agonist Therapy. C-EDGE CO-STAR. Phase . 2. Treatment. . Naïve. Dore G, . et al. . AALSD. 2015; Abstract 40. . Injection Drug Use. *PWID = Persons . W. ho . I. & . Update on HCV . blood bank protocol. . Overview - . diagnostic tests. Serologic . assays: . specific antibody to hepatitis C virus (anti-HCV). Molecular . assays: HCV nucleic acid . (. nucleic.